BNP Paribas Financial Markets’s aTyr Pharma ATYR Stock Holding History

BNP Paribas Financial Markets’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15K	Sell	25,055 -223	-0.9%	-$146	﹤0.01%	5321
2026 Q1	$19.7K	Sell	25,278 -1,240	-5%	-$1.05K	﹤0.01%	5092
2025 Q4	$20.8K	Buy	26,518 +5,823	+28%	+$4.78K	﹤0.01%	5016
2025 Q3	$14.9K	Buy	20,695 +1,145	+6%	+$5.19K	﹤0.01%	4953
2025 Q2	$99.1K	Buy	+19,550	New	+$76.9K	﹤0.01%	4018
2025 Q1	–	Sell	-2	Closed	-$7	–	5618
2024 Q4	$7	Buy	+2	New	+$6	﹤0.01%	5369
2022 Q4	–	Sell	-1,784	Closed	-$5.35K	–	4701
2022 Q3	$5.35K	Buy	+1,784	New	+$5.98K	﹤0.01%	4246
2016 Q2	–	Sell	-7	Closed	-$370	–	3593
2016 Q1	$370	Sell	7 -46	-87%	-$3.5K	﹤0.01%	2573
2015 Q4	$7.34K	Sell	53 -44	-45%	-$6.26K	﹤0.01%	3296
2015 Q3	$13.9K	Buy	+97	New	+$22.1K	﹤0.01%	3385

Other funds holding ATYR

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets's ATYR Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its aTyr Pharma (ATYR) stake by 0.88% in Q2 2026, selling an estimated $146 and leaving 25,055 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #5321.

BNP Paribas Financial Markets first reported a position in ATYR in Q3 2015 and has held it in 10 quarters since. The position peaked at $99.1K in Q2 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

BNP Paribas Financial Markets held 25,055 shares of aTyr Pharma worth $15K as of Q2 2026.
BNP Paribas Financial Markets sold 223 aTyr Pharma shares in Q2 2026, an estimated $146.
aTyr Pharma made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5321 holding.
BNP Paribas Financial Markets first reported a position in aTyr Pharma in Q3 2015 and has held it in 10 quarters since.
BNP Paribas Financial Markets's aTyr Pharma position peaked at $99.1K in Q2 2025.
90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.